la tirzepatide FDA approves Zepbound for weight loss Mounjaro (Tirzepatide) for Medical Weight

The active ingredient semaglutide was approved

Did you hear about orforglipron, the new GLP-1 pill in the headlines this week

Natures Truth: Where Wellness Begins

This article examines why clinicians rarely combine semaglutide and liraglutide, what the evidence shows, and how biomarker and genetic insights can help inform a more personalized medication discus

Discover why UK guidance advises against liraglutide during lactation, understand the safety concerns, and explore evidence-based alternative weight management options suitable for nursing mothers.

A new study has revealed that most Australian women of reproductive age prescribed GLP-1 receptor agonists are not using effective contraception, despite known risks during pregnancy.